CDIO logo

CARDIO DIAGNOSTICS HOLDINGS

CDIONASDAQ
πŸ† #4987 by market capEarnings Mar 3US Equity
$1.60β–Ό $0.05 (βˆ’3.03%)
Market closed Β· at close
πŸ””
Track CDIO
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 3.0%
7dβ–Ό 23.4%
14dβ–Ό 3.6%
30dβ–Ό 6.2%
ytdβ–Ό 44.7%
1yβ–Ό 35.2%
🏦Market Cap
$5M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-57.5%
Declining
πŸ“ŠGross Margin
-523.3%
Thin
πŸ’΅FCF Margin
-38202.8%
Thin
βš–οΈP/S Ratio
311.8x
Expensive
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$1.54 – $1.61
52-Week Range
$0.97 – $7.91
Volume (shares)
32,032
Avg Volume (shares)
β€”
Shares Outstanding
3.0M
Next Earnings
2027-03-03

Fundamentals Snapshot

Annual Revenue
$14,825
Last Q Revenue
$3,590
P/E Ratio
-0.6
P/S Ratio
311.8x
EPS (TTM)
$-2.19
Dividend Yield
0.00%
Dilution (1yr)
βˆ’96.0%
CDIO logo

CARDIO DIAGNOSTICS HOLDINGS

CDIO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$15Kβ–Ό βˆ’57.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
100.0%β–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$6Mβ–Ό βˆ’22.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$6Mβ–² +9.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.8Mβ–Ό βˆ’96.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$4Mβ–Ό βˆ’$2M YoY
StockOtter Β· stockotter.space

About CARDIO DIAGNOSTICS HOLDINGS

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

Business WireΒ·5d ago

Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. will host an investor conference call on Thursday, December 10, 2026, at 11 a.m. Central Time.

Business WireΒ·10d ago

Cardio Diagnostics' Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and Care

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics released a new whitepaper as a resource for clinicians navigating current limitations in detecting and managing NOCAD.

Defense WorldΒ·Oct 19

Critical Analysis: Genmab A/S (NASDAQ:GMAB) versus Cardio Diagnostics (NASDAQ:CDIO)

Genmab A/S (NASDAQ: GMAB - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the stren

Defense WorldΒ·Sep 28

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Shares Shorted: Short Interest Down 77.7% in September

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO - Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 5,259 shares, a drop of 77.7% from

Seeking AlphaΒ·Sep 18

Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript

Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder/Analyst Call Prepared Remarks Transcript

Defense WorldΒ·Aug 29

Cardio Diagnostics (NASDAQ:CDIO) & Sutro Biopharma (NASDAQ:STRO) Head-To-Head Analysis

Sutro Biopharma (NASDAQ: STRO - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses b